• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Organon

Anonymous company board for Organon

Sticky threads

Replies
54
Views
24K
Anonymous

Normal threads

Replies
25
Views
8K
anonymous
Replies
0
Views
614
anonymous
Replies
3
Views
1K
anonymous
Replies
2
Views
2K
anonymous
Replies
1
Views
3K
anonymous
Replies
12
Views
9K
anonymous
Replies
4
Views
4K
anonymous
Replies
0
Views
1K
anonymous
Replies
2
Views
1K
anonymous
Replies
9
Views
12K
Anonymous
Replies
2
Views
7K
Anonymous
Replies
5
Views
7K
Anonymous
Replies
3
Views
4K
Anonymous
Replies
3
Views
5K
Anonymous
Replies
49
Views
22K
Anonymous
Replies
4
Views
4K
Anonymous
Replies
0
Views
3K
Anonymous
Replies
30
Views
15K
Anonymous